HMG1 (high mobility group 1) is a ubiquitous and abundant chromatin component. However, HMG1 can be secreted by activated macrophages and monocytes, and can act as a mediator of inflammation and endotoxic lethality. Here we document a role of extracellular HMG1 in cell migration. HMG1 (and its individual DNA-binding domains) stimulated migration of rat smooth muscle cells in chemotaxis, chemokinesis, and wound healing assays. HMG1 induced rapid and transient changes of cell shape, and actin cytoskeleton reorganization leading to an elongated polarized morphology typical of motile cells. These effects were inhibited by antibodies directed against the receptor of advanced glycation endproducts, indicating that the receptor of advanced glycation endproducts is the receptor mediating the HMG1-dependent migratory responses. Pertussis toxin and the mitogen-activated protein kinase kinase inhibitor PD98059 also blocked HMG1-induced rat smooth muscle cell migration, suggesting that a G(i/o) protein and mitogen-activated protein kinases are required for the HMG1 signaling pathway. We also show that HMG1 can be released by damage or necrosis of a variety of cell types, including endothelial cells. Thus, HMG1 has all the hallmarks of a molecule that can promote atherosclerosis and restenosis after vascular damage.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199202PMC
http://dx.doi.org/10.1083/jcb.152.6.1197DOI Listing

Publication Analysis

Top Keywords

rat smooth
12
smooth muscle
12
hmg1
9
high mobility
8
mobility group
8
cytoskeleton reorganization
8
muscle cells
8
cells hmg1
8
cell migration
8
receptor advanced
8

Similar Publications

NEK2 inhibition reverses vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.

Cell Signal

March 2025

Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Department of Clinical Laboratory Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College; Beijing, China. Electronic address:

Objective: Pulmonary arterial hypertension (PAH) is a serious consequence of congenital heart disease (CHD). PAH is characterized by a cancer-like pro-proliferative and anti-apoptotic phenotype of pulmonary artery smooth muscle cells (PASMCs). Never in mitosis a-related kinase 2 (NEK2) has recently been identified as a key factor in tumor cell proliferation and migration whlie the functional importance of NEK2 in PAH associated with CHD (CHD-PAH) has not been elucidated yet.

View Article and Find Full Text PDF

Maturation represents a process characterized by adaptive changes, particularly in the circulatory system. However, it is not known whether, in neonates, potassium channels contribute to NO-induced vasorelaxation at all and, if so, which potassium channels these are. Therefore, this study tested the hypothesis that potassium channels mediate NO-induced vasorelaxation in newborn rats.

View Article and Find Full Text PDF

Inhibition of LIMK Reduces Contraction and Proliferation in Bladder Smooth Muscle Induced by TGF- β1.

Eur J Pharmacol

March 2025

Department of Urology and Guangdong Key Laboratory of Urology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China. Electronic address:

Overactive bladder (OAB) significantly impacts quality of life and poses substantial healthcare costs. Despite current treatments, there is an unmet need for innovative therapeutic strategies due to limited efficacy and high discontinuation rates. Our study aimed to investigate the role of transforming growth factor-β1 (TGF-β1) in bladder smooth muscle contraction and the potential of Lim kinase (LIMK) inhibitors in reducing TGF-β1-induced effects, offering a novel approach to OAB treatment.

View Article and Find Full Text PDF

Study on HIF-PHI combined with iron supplement in treatment of renal anemia in rats.

BMC Nephrol

March 2025

Department of Nephrology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, Shandong, 250012, P.R. China.

Background: Roxadustat is a novel hypoxia- inducible factor-prolyl hydroxylase inhibitor(HIF-PHI) used to treat anemia in chronic kidney disease (CKD) patients. It has been reported that roxadustat can slow down kidney damage and delay the development of kidney fibrosis. Anemia and iron deficiency are often associated with the vast majority CKD patients, and insufficient available iron or total iron storage is often the most common cause of anemia and ESAs resistance in CKD patients.

View Article and Find Full Text PDF

YBX1, a DNA-/RNA-binding protein, is implicated in various diseases, yet its role in intimal hyperplasia (IH) remains unclear. This study investigates YBX1's function in rat aortic smooth muscle cells (RASMCs) through knockdown experiments. Results show that YBX1 knockdown reduces cell proliferation and migration while inducing apoptosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!